MedPath

The identification of molecular mechanisms and a new biomarker of pancreatic cancer with glucose intolerance.

Not Applicable
Conditions
Pancreatic cancer, Diabetes
Registration Number
JPRN-UMIN000024977
Lead Sponsor
Okayama University
Brief Summary

Specific substances were not detected.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
32
Inclusion Criteria

Not provided

Exclusion Criteria

1.Benign pancreatic disorder 2.Type 1 diabetes 3.Chronic pancreatitis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath